Latest News & Features
Big Pharma
The pair are rapped for overcharging the NHS | Unfair prices for an epilepsy drug lasted four years | Costs leapt from £2m to £50m in one year after the companies' “illegal exploitation” of market position. 22 July 2022
Big Pharma
Global industry body launches declaration | Poorer nations could benefit from more equitable vaccine access | Proposal to be tabled among G7 and G20. 21 July 2022
Americas
California company resolves pay-for-delay issue over opioids | Allegations were brought by direct purchasers eight years ago. 21 July 2022
Americas
Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU. 21 July 2022
Americas
New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office. 19 July 2022
Americas
Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility. 19 July 2022
Big Pharma
EU’s top court denies bid that Amsterdam decision was a “misuse of powers” | Complaint said The Netherlands facility wasn’t ready | Milan lost out after random pick from a fish bowl. 15 July 2022
Big Pharma
A Virginia court was unconvinced that the Hatch-Waxman Act did not apply. 14 July 2022
Americas
Generics giant’s petition cites the cost of medicine and first-principles of innovation. 14 July 2022
Americas
New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology. 14 July 2022